thalidomide has been researched along with Hyperkalemia in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harris, E | 1 |
Behrens, J | 1 |
Samson, D | 1 |
Rahemtulla, A | 1 |
Russell, NH | 1 |
Byrne, JL | 1 |
Fakhouri, F | 2 |
Guerraoui, H | 1 |
Presne, C | 1 |
Peltier, J | 1 |
Delarue, R | 1 |
Muret, P | 1 |
Knebelmann, B | 2 |
Izzedine, H | 1 |
Launay-Vacher, V | 1 |
Deray, G | 1 |
Terrier, B | 1 |
Joly, D | 1 |
Ghez, D | 1 |
Hummel, A | 1 |
4 other studies available for thalidomide and Hyperkalemia
Article | Year |
---|---|
Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia.
Topics: Acute Kidney Injury; Aged; Angiogenesis Inhibitors; Female; Humans; Hyperkalemia; Male; Middle Aged; | 2003 |
Thalidomide in patients with multiple myeloma and renal failure.
Topics: Aged; Angiogenesis Inhibitors; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Middle A | 2004 |
Thalidomide for the nephrologist.
Topics: Acute Kidney Injury; Angiogenesis Inhibitors; Humans; Hyperkalemia; Thalidomide | 2005 |
Reversible paraparesis in multiple myeloma with renal failure.
Topics: Acute Kidney Injury; Combined Modality Therapy; Follow-Up Studies; Humans; Hyperkalemia; Kidney Func | 2006 |